Table 3 Neuroendocrine Profile
| n = 4 | Genes associated with this histologic typeb | |||||
| Age | APC | P16 | ||||
| Range | 13–40 | FHIT | PTEN | |||
| Mean | 29 | FGFR1 | RB | |||
| Median | 32 | KRAS | SOX | |||
| BMI | MCC | TP53 | ||||
| Range | 21.5–39.5 | MEN-2 | ||||
| Mean | 29.1 | MYCL | ||||
| Median | 27.7 | |||||
| Survival | ||||||
| Range | 189–596 | |||||
| Mean | 366 | |||||
| Median | 339.5 | |||||
| Chemo | Rad | Alive | Novel Targets | Profiles | ||
| Location | ||||||
| Ovary | 2 (50%) | Plat/Etoposide | 0 | 1 (50%) |
AKAP9 (1) ASXL1 (1) MBD1 (1) ALK (1) GPR124 (1) KMT2D (1) |
AKAP9, ASXL1, MBD1 (1) ALK, GPR124, KMT2D (1)a |
| Cervix | 1 (25%) | Plat/Etoposide | 1 | 1 (100%) |
AKAP9 (1) ASXL1 (1) CMPK1 (1) | AKAP9, ASXL1, CMPK1 (1) |
| Endometrial | 1 (25%) | Carbo/Taxol | 1 | 0 (0%) |
ROS1 (1) ALK (1) ERBB3 (1) GPR124 (1) KMT2D (1) NTRK1 (1) | ROS1, ALK, ERBB3, GPR124, KMT2D, NTRK1 (1)a |
